Jun 02, 2020
Seattle Plastic Surgeon Uses Human Donated Placenta To Grow Hair
May 27, 2020
Bio Products Laboratory Announces Launch of ALBUMINEX® 5% and ALBUMINEX® 25% With Supply Immediately Available in the United States
May 14, 2020
Cellphire Announces Orphan Drug Designation of Thrombosomes® for Treatment of Acute Radiation Syndrome
May 14, 2020
The Global Platelet Rich Plasma Market is expected to grow from USD 210.30 Million in 2018 to USD 489.23 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 12.81%
May 13, 2020
Global Plasma Therapy Market is Anticipated to Register for $432.8 Million by 2026 Despite COVID-19 Pandemic - Research Dive
May 11, 2020
Impact on Global Plasma Therapy Market in Wake of COVID-19 Pandemic
May 01, 2020
BPL Plasma to Join Fight Against Coronavirus
Apr 30, 2020
China National Medical Products Administration Approves DOPTELET® (avatrombopag) for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure
Apr 24, 2020
PPTA Applauds Administration for Focus on Plasma Donation
Apr 23, 2020
COVID-19 Antibody Therapy Treatment Advances At SCL Health
Apr 20, 2020
People Who Have Recovered from COVID-19 Can Now Donate their Convalescent Plasma in select Grifols U.S. Plasma Donor Centers
Apr 02, 2020
Convalescent plasma donations to be collected by Versiti Blood Centers to treat COVID-19 patients
Mar 25, 2020
Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19
Mar 18, 2020
Cellphire Begins Phase 2 Trial of Thrombosomes® in Bleeding Thrombocytopenic Patients
Mar 02, 2020
Cablivi® (caplacizumab) approved by Health Canada for adults living with acquired thrombotic thrombocytopenic purpura (aTTP)
Mar 02, 2020
Cablivi® (caplacizumab) approved by Health Canada for adults living with acquired thrombotic thrombocytopenic purpura (aTTP)
Mar 02, 2020
Cablivi® (caplacizumab) approved by Health Canada for adults living with acquired thrombotic thrombocytopenic purpura (aTTP)
Feb 26, 2020
Covetrus North America Now Offers Unique In-Clinic Regenerative Medicine Devices by Enso Discoveries, LLC Including Rebound PRP(TM) and Rebound PRF®
Feb 25, 2020
EmCyte Announces FDA 510(k) Clearance for its PurePRP® Supraphysiologic Concentrating System
Feb 20, 2020
EmCyte Announces the Acquisition of the Centrepid Platelet Concentrator